SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001140361-24-028104
Filing Date
2024-05-30
Accepted
2024-05-30 16:02:59
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-3 ny20028941x1_s3.htm S-3 332365
2 EXHIBIT 5.1 ny20028941x1_ex5-1.htm EX-5.1 7366
3 EXHIBIT 23.1 ny20028941x1_ex23-1.htm EX-23.1 2162
4 EXHIBIT 23.2 ny20028941x1_ex23-2.htm EX-23.2 2256
5 EXHIBIT 99.1 ny20028941x1_ex99-1.htm EX-99.1 60264
6 FILING FEES TABLE ny20028941x1_ex107.htm EX-FILING FEES 37218
7 logo_gyre.jpg GRAPHIC 26811
8 logo_gyrex1.jpg GRAPHIC 32791
9 ny20028941x1_ex5-1img01.jpg GRAPHIC 120814
  Complete submission text file 0001140361-24-028104.txt   691135
Mailing Address 12770 HIGH BLUFF DRIVE, SUITE 150 SAN DIEGO CA 92130
Business Address 12770 HIGH BLUFF DRIVE, SUITE 150 SAN DIEGO CA 92130 (619) 949-3681
GYRE THERAPEUTICS, INC. (Filer) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-279820 | Film No.: 241005106
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)